TELA BIO INC's ticker is TELA and the CUSIP is 872381108. A total of 50 filers reported holding TELA BIO INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,094,680 | -21.9% | 136,835 | -1.2% | 0.00% | – |
| Q2 2023 | $1,402,367 | +537.0% | 138,437 | +569.1% | 0.00% | – |
| Q1 2023 | $220,152 | +2.7% | 20,691 | +11.0% | 0.00% | – |
| Q4 2022 | $214,383 | +84.8% | 18,642 | +37.3% | 0.00% | – |
| Q3 2022 | $116,000 | +18.4% | 13,576 | -3.0% | 0.00% | – |
| Q2 2022 | $98,000 | -43.4% | 13,994 | -6.2% | 0.00% | – |
| Q1 2022 | $173,000 | -9.4% | 14,912 | 0.0% | 0.00% | – |
| Q4 2021 | $191,000 | -6.4% | 14,912 | 0.0% | 0.00% | – |
| Q3 2021 | $204,000 | -7.7% | 14,912 | +8.7% | 0.00% | – |
| Q2 2021 | $221,000 | -80.4% | 13,716 | -81.9% | 0.00% | – |
| Q1 2021 | $1,130,000 | -2.2% | 75,839 | -1.3% | 0.00% | – |
| Q4 2020 | $1,156,000 | -12.5% | 76,871 | -3.7% | 0.00% | – |
| Q3 2020 | $1,321,000 | +441.4% | 79,838 | +324.3% | 0.00% | – |
| Q2 2020 | $244,000 | +82.1% | 18,815 | +81.8% | 0.00% | – |
| Q4 2019 | $134,000 | – | 10,348 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,833,989 | $25,052,000 | 5.56% |
| Opaleye Management Inc. | 443,199 | $6,054,000 | 1.13% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 113,000 | $1,544,000 | 0.56% |
| Orbimed Advisors | 3,027,542 | $41,356,000 | 0.45% |
| Parkman Healthcare Partners LLC | 100,000 | $1,366,000 | 0.35% |
| RTW INVESTMENTS, LP | 1,391,619 | $19,010,000 | 0.29% |
| SANDERS MORRIS HARRIS LLC | 107,168 | $1,464,000 | 0.27% |
| COWEN AND COMPANY, LLC | 392,100 | $5,356,000 | 0.25% |
| PURA VIDA INVESTMENTS, LLC | 580,515 | $7,930,000 | 0.24% |
| Granite Point Capital Management, L.P. | 227,644 | $3,110,000 | 0.24% |